|国家科技期刊平台
首页|期刊导航|中国药理学通报|干扰素基因刺激因子激动剂的研究进展

干扰素基因刺激因子激动剂的研究进展OA北大核心CSTPCD

Research progress of STING agonists

中文摘要英文摘要

cGAS-STING通路作为固有免疫系统的重要组成部分,可以识别来自病原微生物和宿主细胞的胞质DNA,诱导Ⅰ型干扰素的分泌和炎症细胞因子的生成,激活机体免疫系统,抵抗病原微生物的入侵及增强机体抗肿瘤活性等.该文简要介绍了 cGAS-STING通路的生物学功能,主要聚焦于STING激动剂的研究进展,包括CDN类和Non-CDN类STING激动剂的药理作用及其研究阶段,总结与展望STING激动剂研发过程中的问题与挑战,以期为后续相关药物的研发和疾病治疗提供思路.

As an important part of the innate immune system,the cGAS-STING pathway can recognize cytoplasmic DNA from pathogenic microorganisms and host cells,induce the secretion of type Ⅰ interferon and the production of inflammatory cytokines,activate the immune system,resist the invasion of pathogenic mi-croorganisms,and enhance antitumor activity.Here we briefly introduce the mechanism and biological functions of the cGAS-STING pathway,focus on the current research progress of STING agonists,including the pharmacological effects and research sta-ges of STING CDN and Non-CDN agonists,and finally summari-zes and prospects the problems and challenges in the research of STING agonists,in order to provide ideas for the development of related drugs and disease treatment.

王娅;吴硕;李玉环

中国医学科学院北京协和医学院医药生物技术研究所,中国医学科学院抗病毒药物研究重点实验室,抗感染药物研究北京市重点实验室,北京 100050

基础医学

cGAS-STING通路免疫应答STING激动剂Ⅰ型干扰素抗肿瘤免疫抗感染免疫

cGAS-STING pathwayimmune responseSTING agoniststype Ⅰ interferonantitumor immunityanti-infection immunity

《中国药理学通报》 2024 (004)

611-618 / 8

国家自然科学基金青年项目(No 81803592);中国医学科学院医学与健康科技创新工程项目(No 2021-1-I2M-030)

10.12360/CPB202206050

评论